Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • mitchum20
    Junior Member
    • Mar 2018
    • 6

    #1

    Limits of Indel Detection

    Dear all,

    I am wondering if there is a maximum possible indel length, which is still detectable in an alignment of paired-end 150bp Illumina reads.

    I am using the BCFtools package to call Indels on novoaligned short reads and noticed that called indels dont exceed a certain number like 70bp.

    Thank you for your comments.
  • Meyana
    Member
    • Sep 2017
    • 40

    #2
    Might be a limit to the indel caller.

    I'd suggest using bbmap for mapping and CallVariants (also in the BBtools suite), I'm successfully calling long (>10kb) indels using 150bp paired end reads using these tools.

    Comment

    • mitchum20
      Junior Member
      • Mar 2018
      • 6

      #3
      Thanks your suggestion. Can you suggest me a handbook or guide for this method ?

      Comment

      • Meyana
        Member
        • Sep 2017
        • 40

        #4
        Please refer to the bbtools manual here:
        Fast, multithreaded bioinformatics tools for DNA/RNA analysis. Over 90 tools for alignment, assembly, QC, and analysis.


        And the callvariants page here:
        Multi-threaded Distributed Memory Overlap-Layout-Consensus (OLC) Metagenome Assembler - abiswas-odu/Disco


        You could likely just follow the recommended/default parameters and see where that gets you first. Then, if there's something you're not picking up (I like to compare with how the data looks in IGV) try fiddling with the parameters.

        Please also take a look at the BBMAP thread on this forum (lots of goodies!) or this thread by GenoMax (http://seqanswers.com/forums/showthread.php?t=58221), but feel free to ask if you have something more specific

        Only thing I would like to point out: For my data, the kmer value set during mapping influences indel calling a lot. Please use the default setting first, in my experience lowering it did bad things to my indel calling....

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Today, 02:55 AM
        0 responses
        4 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        10 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        11 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        23 views
        0 reactions
        Last Post SEQadmin2  
        Working...